Log in

NHMRC Centre for Blood Transplant and Cell Therapies Webinar 27 September 2021

30 Aug 2021 12:42 PM | Anonymous member (Administrator)

The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, speakers will review major topics in stem cell transplantation and cell therapy, highlighting how key advances are addressing the current challenges in stem cell transplantation. The ninth webinar in this series features Professor Catherine Bollard, who is the current Program Director for Cell Enhancement and Technologies at the Children’s National Hospital and Professor of Pediatrics and Microbiology, Immunology and Tropical Medicine at the George Washington University. Her bench and translational research has focused on improving post-transplant outcomes through developing novel cellular therapeutics, leading to over 200 peer reviewed publications. In this webinar, Professor Bollard will be outlining the role of virus-specific T cell therapies following transplantation as well as their potential applications for treating COVID-19.


Professor Catherine Bollard – Children’s National Hospital and George Washington University

 When: Monday 27 September 2021, 8am AEST

 Link to webinar:

Link to CBTCT website for all webinar recordings:

For more information click here


Haematology Society of Australia and New Zealand (HSANZ)
145 Macquarie Street, Sydney NSW 2000
Tel: 02 8097 8114


Copyright © 2020 Haematology Society of Australia & New Zealand (HSANZ). All Rights Reserved.

Powered by Wild Apricot Membership Software